X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1030) 1030
Conference Proceeding (65) 65
Publication (37) 37
Patent (30) 30
Book Chapter (20) 20
Dissertation (7) 7
Book / eBook (5) 5
Report (5) 5
Technical Report (2) 2
Data Set (1) 1
Paper (1) 1
Reference (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (184) 184
humans (144) 144
materials science, multidisciplinary (111) 111
analysis (109) 109
male (81) 81
female (75) 75
physics, condensed matter (69) 69
animals (67) 67
chemistry, multidisciplinary (64) 64
nanoparticles (63) 63
chemistry, physical (58) 58
physics, applied (54) 54
india (47) 47
x-ray diffraction (40) 40
chemistry (39) 39
middle aged (38) 38
physics (37) 37
adult (36) 36
growth (36) 36
nanotubes (36) 36
materials science (35) 35
research (34) 34
graphene (33) 33
otorhinolaryngology (33) 33
surgery (33) 33
nanostructures (30) 30
electrical conductivity (29) 29
physics, atomic, molecular & chemical (29) 29
cell biology (28) 28
chemical synthesis (28) 28
electrical properties (28) 28
engineering, electrical & electronic (28) 28
biochemistry & molecular biology (27) 27
electric properties (27) 27
iron (27) 27
mice (27) 27
nanoscience & nanotechnology (27) 27
rats (27) 27
ac conductivity (26) 26
aged (26) 26
spectroscopy (26) 26
cancer (25) 25
carbon nanotubes (25) 25
cells (25) 25
crystal structure (25) 25
magnetic properties (25) 25
performance (25) 25
studies (25) 25
morphology (23) 23
activation energy (22) 22
films (22) 22
genetics & heredity (22) 22
life sciences (22) 22
nanorods (22) 22
synthesis (22) 22
apoptosis (21) 21
fluorescence (20) 20
methods (20) 20
nanocomposites (20) 20
spectra (20) 20
annealing (19) 19
behavior (19) 19
care and treatment (19) 19
conductivity (19) 19
impedance spectroscopy (19) 19
nanostructure (19) 19
nanowires (19) 19
proteins (19) 19
alloys (18) 18
article (18) 18
carbon (18) 18
environmental sciences (18) 18
mathematical models (18) 18
nanocrystals (18) 18
raman spectroscopy (18) 18
spectrum analysis (18) 18
transport (18) 18
agronomy (17) 17
chemical properties (17) 17
health aspects (17) 17
mitochondrial dna (17) 17
mutation (17) 17
nanopartikel (17) 17
relaxation (17) 17
temperature (17) 17
treatment outcome (17) 17
adsorption (16) 16
genetic aspects (16) 16
medical research (16) 16
medicine (16) 16
patients (16) 16
usage (16) 16
abridged index medicus (15) 15
binding (15) 15
calculating (15) 15
ceramics (15) 15
characterization and evaluation of materials (15) 15
computing (15) 15
counting (15) 15
electric digital data processing (15) 15
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, ISSN 0027-8424, 07/2013, Volume 110, Issue 29, pp. 11704 - 11707
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2017, Volume 377, Issue 12, pp. 1119 - 1131
Patients with myocardial infarction and a high-sensitivity CRP level of 2 mg or more per liter were assigned to one of three canakinumab doses or placebo. The... 
C-REACTIVE PROTEIN | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | MYOCARDIAL-INFARCTION | STATIN THERAPY | CLONAL HEMATOPOIESIS | INFLAMMATION | CARDIOVASCULAR-DISEASE | INTERLEUKIN-1-BETA INHIBITION | RISK | CORONARY-ARTERY-DISEASE | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Secondary Prevention | Infection - etiology | Incidence | Dose-Response Relationship, Drug | Anti-Inflammatory Agents - adverse effects | C-Reactive Protein - metabolism | Lipids - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Anti-Inflammatory Agents - administration & dosage | Female | Neutropenia - chemically induced | Interleukin-1beta - antagonists & inhibitors | Stroke - prevention & control | Atherosclerosis - drug therapy | Double-Blind Method | Interleukin-1beta - immunology | Atherosclerosis - blood | Myocardial Infarction - drug therapy | Antibodies, Monoclonal - administration & dosage | Aged | Myocardial Infarction - prevention & control | Myocardial infarction | Cerebral infarction | Stroke | Heart attacks | C-reactive protein | Cytokines | Clinical trials | Cardiovascular disease | Innate immunity | Inflammation | Angina | Angina pectoris | Thrombosis | Cholesterol | Disease prevention | Proteins | Arteriosclerosis | Atherosclerosis | Cardiovascular diseases | Health risk assessment | Drug therapy | Drug dosages | Klinisk medicin | Clinical Medicine
Journal Article
Journal of Molecular Structure, ISSN 0022-2860, 12/2017, Volume 1150, pp. 88 - 95
Green and highly efficient one-pot three component approach for the synthesis of benzo[ ]quinazoline derivatives ( ) using Choline chloride-urea (DES).... 
DES | DFT | 2-Hydroxy naphthoquinone | Molecular docking | Anticancer activity | ACTIVATION | NAPHTHOQUINONE DERIVATIVES | DFF | QUINAZOLINE | ANTIALLERGIC ACTIVITIES | CHEMISTRY, PHYSICAL | INDUCTION | IN-VITRO CYTOTOXICITY | ANTIPLATELET | LUNG-CANCER | BIOLOGICAL EVALUATION | INHIBITOR | Urea | Lymphomas | Lung cancer | Choline | Biological products
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2012, Volume 367, Issue 4, pp. 319 - 328
In this study with a 2-by-2 factorial design, patients with cardiovascular risk factors and dysglycemia or type 2 diabetes received insulin glargine or... 
DIABETES-MELLITUS | MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | THERAPY | GLARGINE | GLUCOSE CONTROL | DISEASE | RISK | PEOPLE | ENDOTHELIAL FUNCTION | BETA-CELL FUNCTION | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Middle Aged | Male | Incidence | Glucose Intolerance - drug therapy | Cardiovascular Diseases - epidemiology | Female | Drug Therapy, Combination | Hypoglycemia - chemically induced | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Fasting | Blood Glucose - analysis | Double-Blind Method | Proportional Hazards Models | Hospitalization | Glucose Intolerance - complications | Insulin, Long-Acting - adverse effects | Insulin Glargine | Insulin, Long-Acting - therapeutic use | Intention to Treat Analysis | Triglycerides - blood | Fatty Acids, Omega-3 - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Care and treatment | Insulin glargine | Patient outcomes | Causes of | Cardiovascular diseases | Risk factors | Myocardial infarction | Fees & charges | Cerebral infarction | Medical research | Stroke | Heart attacks | Statistical analysis | Diabetes mellitus | Glucose | Hypoglycemia | Fatty acids | Insulin | Glucose tolerance | Insulin resistance | Microvasculature | Diabetes | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Cardiovascular Diseases | Insulin, Long-Acting | Blood Glucose | Triglycerides | Glucose Intolerance | Cholesterol | Life Sciences | Hypoglycemic Agents | Diabetes Mellitus, Type 2 | Fatty Acids, Omega-3 | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article